Clinical trials: Subclinical Breast Cancer Lesion
Toxicity Due to Radiotherapy, Breast Cancer
REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)
The purpose of this study is to determine whether a new technique of radiotherapy for breast cancer (helical tomotherapy) can induce cardiac toxicity that would be detected in the first two years after treatment.
- Conditions
- Toxicity Due to Radiotherapy, Breast Cancer, Lesion; Cardiac
- Trial name
- REBECCA (NCT02079272)
- Testing
- Helical tomotherapy for breast cancer
- Where
- France
- Sponsor
- Sophie JACOB
Breast Cancer, Cardiac Toxicity
BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study
Breast radiotherapy RT used until the 1990s was clearly responsible for increased mortality due to long term cardiac complications.
- Trial name
- BACCARAT (NCT02605512)
- Testing
- Subclinical cardiac lesions and biomarkers
- Where
- France
- Volunteers
- 118 people
- Sponsor
- Sophie JACOB
Subclinical Breast Cancer Lesion
Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery
Breast cancer is diagnosed by imaging at a non-palpable stage in more than half of all cases. Surgical removal requires preoperative guidance.
- Trial name
- AR-GBS (NCT06512558)
- Testing
- Additional MRI with gadolinium injection and 3D camera imaging
- Where
- France
- Volunteers
- 20 people
- Sponsor
- Centre Jean Perrin